Moberg Adds DermoPlast Line With Bondholders' Blessing For More
This article was originally published in The Pink Sheet
Moberg says sales of DermoPlast sprays were $12m in the 12 months through September and its purchase price is around 8.9 times the estimated EBITDA for the brand during the period.
You may also be interested in...
Mylan's Schloss joins CHPA government affairs; Catalent expands softgel capabilities with Accucaps acquisition; GKSk recalls a half million bottles of mislabeled Zeasorb; and more news in brief.
The Swedish firm pays $40m for the PediaCare and Fiber Choice brands in addition to New Skin Liquid Bandages, which are available in spray and liquid delivery and are "the main profitability contributor in the acquired portfolio," says CEO Peter Wolpert.
Perrigo largely has resolved distribution problems, but shipping freight costs still are much higher than pre-pandemic and it must divest a wound-care brand before US regulators sign off on acquisition of HRA Pharma, says CEO Murray Kessler during J.P. Morgan conference.